Home Featured Page 179

Featured

Latest

Review: Colorado Psychedelic Cup 2025

Dr Ros Watts – Building Communities and Connection

The Psychedelic News Feed: October 27 – November 02, 2025

Compass Pathways Accelerates Psilocybin Launch Timeline by 9-12 Months

CLOSING RECEPTION Travis Gillan’s Revelator

Entheon Biomedical Announces EBIQ-101 First-Patient Dose

COMPASS Pathways announces financial results for the fourth quarter and full...

MindMed Converts Multiple Voting Shares to Subordinate Voting Shares

PharmaDrug Receives Positive Results for DMT-Analogue Program to Treat Glaucoma

Filament Health and ATMA Journey Centers Announce Licensing Agreement

PT296 – Dr. David Luke – Vital Psychedelic Conversations

Reclaiming Ownership of Your Body With Psychedelics

Tackling Trauma with Pharmahuasca and DMT

World’s First Clinical Trial for DMT-Assisted Therapy in Major Depressive Disorder...

PT295 – Sidarta Ribeiro – Dreams, LSD, and Biopiracy

1...178179180...301 Page 179 of 301

Review: Colorado Psychedelic Cup 2025

Dr Ros Watts – Building Communities and Connection

The Psychedelic News Feed: October 27 – November 02, 2025

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Review: Colorado Psychedelic Cup 2025

Dr Ros Watts – Building Communities and Connection

The Psychedelic News Feed: October 27 – November 02, 2025

Compass Pathways Accelerates Psilocybin Launch Timeline by 9-12 Months

CLOSING RECEPTION Travis Gillan’s Revelator

Entheon Biomedical Announces EBIQ-101 First-Patient Dose

COMPASS Pathways announces financial results for the fourth quarter and full...

MindMed Converts Multiple Voting Shares to Subordinate Voting Shares

PharmaDrug Receives Positive Results for DMT-Analogue Program to Treat Glaucoma

Filament Health and ATMA Journey Centers Announce Licensing Agreement

PT296 – Dr. David Luke – Vital Psychedelic Conversations

Reclaiming Ownership of Your Body With Psychedelics

Tackling Trauma with Pharmahuasca and DMT

World’s First Clinical Trial for DMT-Assisted Therapy in Major Depressive Disorder...

PT295 – Sidarta Ribeiro – Dreams, LSD, and Biopiracy

EDITOR PICKS

Review: Colorado Psychedelic Cup 2025

Dr Ros Watts – Building Communities and Connection

The Psychedelic News Feed: October 27 – November 02, 2025

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY